Core Viewpoint - The company plans to repurchase its issued H-shares in the open market, with a total repurchase price not exceeding HKD 100 million, indicating confidence in its business outlook and prospects [1] Group 1: Repurchase Plan - The company intends to exercise its H-share repurchase authorization under appropriate market conditions [1] - The repurchase will be funded through internal resources and will not utilize proceeds from the initial public offering of H-shares [1] - The board believes that the repurchase will enhance the company's value and protect shareholder interests [1] Group 2: Compliance and Financial Health - The repurchase will comply with the company's articles of association, Hong Kong Stock Exchange listing rules, and applicable laws and regulations [1] - The board is confident that the company's current internal resources will allow it to maintain a sound financial position while executing the repurchase [1] - The company will consider canceling or holding the repurchased H-shares in treasury at an appropriate time [1]

Key Points - The company plans to repurchase shares with an amount not less than RMB 200 million and not exceeding RMB 400 million [2] - The funding sources for the repurchase include a special loan from Shanghai Pudong Development Bank and the company's own funds, with the loan amount not exceeding RMB 360 million [2][11] - The repurchased shares will be used for converting the company's convertible bonds [2][17] - The maximum repurchase price is set at RMB 16.84 per share, which is 150% of the average trading price over the last 30 trading days prior to the board's decision [2][10] - The repurchase will be conducted through centralized bidding and is expected to take place within 12 months from the board's approval [2][7] - There are no clear plans for share reduction from major shareholders in the next three to six months [2][14] Repurchase Plan Details - The purpose of the repurchase is to enhance investor confidence and reflect the company's belief in its future development [5] - The type of shares to be repurchased is the company's ordinary shares (A-shares) [6] - The implementation period for the repurchase is from January 27, 2026, to January 26, 2027 [7] - The total number of shares expected to be repurchased is approximately 23.75 million, accounting for about 1.37% of the company's total share capital [12] - The company will not repurchase shares during certain periods, such as when significant events that could affect stock prices occur [8] Financial Performance Forecast - The company expects to achieve a net profit attributable to shareholders of RMB 700 million to RMB 800 million for the year 2025, representing an increase of 51.50% to 73.14% compared to the previous year [32][33] - The expected net profit after deducting non-recurring gains and losses is projected to be between RMB 440 million and RMB 528 million, an increase of 29.95% to 55.94% year-on-year [32][33] - The growth in profit is attributed to the company's strategy of upgrading products and customers, expanding overseas markets, and improving operational efficiency through digitalization [37]

Group 1 - The company Xuanwu Cloud (02392) announced a share buyback plan [1] - The company will spend HKD 8,600.08 to repurchase 6,000 shares [1] - The buyback price per share ranges from HKD 1.41 to HKD 1.43 [1]

Group 1 - The company, Jintian Co., Ltd. (601609.SH), announced a share buyback plan intended for the conversion of its convertible bonds [1] - The total amount for the share buyback will be no less than RMB 200 million and no more than RMB 400 million [1] - The maximum buyback price is set at RMB 16.84 per share [1]

康臣药业(01681)发布公告，于2025年6月13日，董事局决议执行股份回购计划，以资金总数不超过2亿 港元为限，于公开市场适时回购股份(先前股份回购计划)。于2026年1月29日，董事局决议根据购回授 权进一步执行另一项股份回购计划，以于公开市场适时回购股份，除先前股份回购计划的资金总数外， 额外增加最多1亿港元(股份回购计划)。据此股份回购计划合计拟动用资金总额将不超过3亿港元。股份 回购计划之期限自本公告日期起至公司下届股东周年大会结束时止或股东于股东大会上撤回或修订购回 授权为止。 董事局对公司的业务发展及前景充满信心，认为公司目前的股价并未充分反映其内在价值及长期增长潜 力。董事局相信，取决于当时的市况及筹资安排，股份回购计划符合公司长期发展战略。实施股份回购 计划将会优化公司资本结构的管理，并提高每股资产净值及╱或每股盈利，符合公司和股东的整体利 益。 ...

Core Viewpoint - 康臣药业 has announced a share buyback plan totaling up to HKD 300 million, reflecting confidence in its business development and long-term growth potential [1] Group 1: Share Buyback Plan - The board of 康臣药业 has resolved to execute a share buyback plan on June 13, 2025, with a total fund not exceeding HKD 200 million for repurchasing shares in the open market [1] - An additional share buyback plan was approved on January 29, 2026, allowing for an extra fund of up to HKD 100 million, bringing the total potential fund for share buybacks to HKD 300 million [1] - The duration of the share buyback plan will last from the announcement date until the conclusion of the next annual general meeting or until the shareholders withdraw or amend the buyback authorization [1] Group 2: Business Confidence and Strategic Rationale - The board expresses strong confidence in the company's business development and future prospects, believing that the current share price does not fully reflect its intrinsic value and long-term growth potential [1] - The implementation of the share buyback plan is seen as aligning with the company's long-term development strategy, optimizing capital structure management, and potentially increasing net asset value per share and/or earnings per share, benefiting both the company and its shareholders [1]

声明：市场有风险，投资需谨慎。本文为AI大模型基于第三方数据库自动发布，任何在本文出现的信 息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成 个人投资建议。受限于第三方数据库质量等问题，我们无法对数据的真实性及完整性进行分辨或核验， 因此本文内容可能出现不准确、不完整、误导性的内容或信息，具体以公司公告为准。如有疑问，请联 系biz@staff.sina.com.cn。 责任编辑：小浪快报 2026年1月29日，城投控股（sh600649）触及涨停，涨停价5.61元，涨幅10%，总市值140.50亿元，流通 市值140.50亿元，截止发稿，总成交额5.74亿元。 根据喜娜AI异动分析，城投控股涨停原因可能如下，业绩增长+股份回购+租赁业务稳定： 1、公司2025 年三季度业绩大幅增长，营业收入同比增长1264.26%，净利润扭亏为盈，显示出短期业绩的爆发，这 可能是刺激股价涨停的重要因素。公司已完成5000万元股份回购，接近计划下限，表明公司对自身价值 的认可，增强了市场信心。 2、公司的租赁业务相对稳定，商业物业出租率66%左右，能提供稳定的现 金流支撑。同时新增竣 ...

和铂医药-B(02142)发布公告，根据公司股东于公司2025年6月11日举行的股东周年大会上批准的购回股 份的一般授权及(如适用)未来股东于公司不时的股东大会上批准的购回股份的任何一般授权，其拟不时 于公开市场上购回价值不超过3亿港元的公司股份。 ...

Core Viewpoint - The company has successfully completed its first share repurchase plan for 2025 and is currently implementing its second share repurchase plan, aimed at employee stock ownership and equity incentives. Group 1: First Share Repurchase Plan - The first share repurchase plan was approved on September 11, 2025, allowing the company to repurchase shares at a price not exceeding RMB 40.69 per share, with a total fund of no less than RMB 30 million and no more than RMB 55 million [2] - The company repurchased a total of 1,920,400 shares, with a total expenditure of RMB 54,976,441.96 (excluding transaction fees) by December 2, 2025 [2][6] - The details of the first repurchase plan were disclosed on the Shanghai Stock Exchange on December 4, 2025 [3] Group 2: Second Share Repurchase Plan - The second share repurchase plan was approved on November 24, 2025, allowing repurchases at a price not exceeding RMB 45.75 per share, with a total fund of no less than RMB 20 million and no more than RMB 45 million [4] - The company is currently executing the second repurchase plan, having repurchased 77,600 shares as of January 28, 2026, with a total expenditure of RMB 2,306,997.00 (excluding transaction fees) [6] - The maximum and minimum prices for the second repurchase were RMB 32.00 and RMB 28.42 per share, respectively [6] Group 3: Overall Repurchase Progress - As of January 28, 2026, the total shares repurchased under both plans amounted to 1,998,000 shares, representing 1.0001% of the company's total share capital [5] - The company will continue to adhere to relevant regulations and disclose information regarding the share repurchase progress in a timely manner [7]

具体内容详见公司2025年12月31日披露于上海证券交易所（www.sse.com.cn）的《关于以集中竞价交易 方式回购股份方案的公告暨回购报告书》（公告编号：2025-072）。 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688026 证券简称：洁特生物 公告编号：2026-007 转债代码：118010 转债简称：洁特转债 广州洁特生物过滤股份有限公司 关于以集中竞价交易方式首次回购公司股份的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ■ 一、回购股份的基本情况 广州洁特生物过滤股份有限公司（以下简称"公司"）于2025年12月29日召开第四届董事会第二十六次会 议，审议通过了《关于以集中竞价交易方式回购公司股份的议案》，同意公司使用自有资金以集中竞价 交易方式回购公司股份。本次回购的股份将在未来适宜时机用于员工持股计划或股权激励。回购资金总 金额不低于人民币1,500万元（含）且不超过人民币3,000万元（含），回购股份价格不超过人民币25.32 元/股（含），回购股份期限为 ...